This antibody is validated for ELISA and Western blotting (WB), with protocols optimized for high specificity .
ELISA: Used in sandwich assays to quantify native DVL1P1 in biological samples (e.g., serum, tissue homogenates) . The biotin-streptavidin system enhances sensitivity, with detection limits typically in the picogram range .
Western Blotting: Detects DVL1P1 at dilutions of 1:500–1:2000, though validation data specific to DVL1P1 remains limited compared to its homolog DVL1 .
Application | Recommended Dilution | Buffer/Conditions |
---|---|---|
ELISA | 1:50–1:500 | PBS-based buffers, pH 7.4 |
Western Blot | 1:500–1:2000 | Tris-glycine SDS-PAGE, non-reducing |
Wnt Signaling Studies: DVL1P1 shares structural motifs with DVL1, a key mediator of Wnt/β-catenin and planar cell polarity pathways . While DVL1P1’s functional role remains unclear, its antibody enables pseudogene-specific investigations in cancer and developmental biology .
Proteomic Profiling: Biotin conjugation allows integration with streptavidin-HRP or fluorescent tags, facilitating single-cell proteomics and multiplexed assays .
Specificity Challenges: Cross-reactivity with DVL1 is a concern due to sequence homology . Negative controls (e.g., isotype-matched antibodies) are essential .
Limited Validation: Published data on DVL1P1-specific applications are sparse compared to DVL1, necessitating user optimization .
Recent advances in spatial proteomics and cell-surface biotinylation leverage this antibody for neuron-astrocyte interaction studies and Wnt pathway dysregulation analyses . Its compatibility with DNA-barcoded streptavidin (e.g., TotalSeq) supports single-cell sequencing workflows .